| Literature DB >> 35805699 |
Zhenlan Li1,2, Tian Wang1, Mengyue Shen3, Tao Song1,4, Jie He1, Wei Guo3, Zhen Wang3, Jie Zhuang1.
Abstract
The objective of this study was to investigate the therapeutic effect of Wuqinxi Qigong vs. stretching on single- and dual-task gait, motor symptoms, and quality of life in people with mild and moderate Parkinson's disease (PD). This single-blind, randomized control trial included 40 participants with idiopathic PD who were randomized into the Wuqinxi Qigong (WQ) group or stretching group. Participants completed 12 weeks (two sessions/week) of intervention. The primary outcomes were gait parameters when performing single-task (comfortable pace) and dual-task (obstacle crossing, serial-3 subtraction and backward digit span) walking, including gait speed, stride length, and double support percentage. The secondary outcomes were ratings from the Movement Disorder Society Unified Parkinson's Disease Rating Scale (MDS-UPDRS), results of the timed-up-and-go test (TUGT), results of the Mini-Balance Evaluation Systems Test (MiniBESTest), and responses from the 39-item Parkinson's Disease Questionnaire (PDQ-39). All measures were assessed pre- and post-intervention. The WQ group demonstrated increased gait speed (p = 0.000) during the single task, and increased stride length (p = 0.001, p = 0.021) during the single-task and serial-3 subtraction task. Double support percentage significantly decreased (p = 0.004) in the WQ group during the obstacle crossing task, and also decreased (p = 0.045) in the stretching group during the single-task. TUGT (p = 0.005), MiniBESTest (p = 0.023) and PDQ-39 (p = 0.043) in the WQ group significantly improved, and both groups showed significant improvement in MDS-UPDRS after intervention. Wuqinxi Qigong is an effective method to improve single- and dual-task gait. While both exercises improve motor symptoms, Wuqinxi Qigong results in better mobility, balance and quality of life compared to stretching alone.Entities:
Keywords: Parkinson’s disease; Wuqinxi Qigong; dual-task gait; motor symptoms; stretching
Mesh:
Year: 2022 PMID: 35805699 PMCID: PMC9265753 DOI: 10.3390/ijerph19138042
Source DB: PubMed Journal: Int J Environ Res Public Health ISSN: 1660-4601 Impact factor: 4.614
Figure 1Ten forms of Wuqinxi Qigong. (A). Form 1: Raising the tiger’s paws; (B). Form 2: Seizing the prey; (C). Form 3: Colliding with the antlers; (D). Form 4: Running like a deer; (E). Form 5: Rotating the waist like a bear; (F). Form 6: Swaying like a bear; (G). Form 7: Lifting the monkey’s paws; (H). Form 8: Picking fruit; (I). Form 9: Stretching upward; (J). Form 10: Flying like a bird.
Figure 2Flow diagram of the study.
Demographic characteristics and clinical outcomes.
| Demographics and Outcomes | WQ Group | Stretching Group |
|
|---|---|---|---|
| Age (year) | 67.57 ± 3.95 | 70 ± 5.59 | 0.126 |
| Gender (M/F) | 13/7 | 16/4 | 0.288 |
| Education condition (years) | 14.40 ± 1.47 | 14.55 ± 1.36 | 0.739 |
| Disease duration (years) | 6.83 ± 4.09 | 7.76 ± 4.55 | 0.528 |
| H&Y stage, | 0.631 | ||
| 1–1.5 | 10 (50%) | 7 (35%) | |
| 2–2.5 | 7 (35%) | 9 (45%) | |
| 3 | 3 (15%) | 4 (20%) | |
| Freezing of gait, | 9 (45%) | 9 (45%) | 1.000 |
| MDS-UPDRS | 25.05 ± 17.45 | 26.79 ± 20.79 | 0.598 |
| MDS-UPDRSIII | 52.19 ± 26.87 | 47.47 ± 29.25 | 0.646 |
| MMSE | 26.79 ± 2.58 | 28.43 ± 2.58 | 0.157 |
| Falls in the 6 months prior to study, | 3 (15%) | 4 (20%) | 1.000 |
| LEDD (mg/d) | 450 ± 252.98 | 450 ± 164.99 | 1.000 |
Note. MDS-UPDRS: Movement Disorder Society-the Unified Parkinson’s Disease Rating Scale; H&Y: Hoehn and Yahr stage; LEDD: levodopa equivalent daily dose; MMSE: Mini-Mental State Examination; Education condition: primary school-six years, junior high school-three years, senior high school-three years, college-four or three years; WQ: Wuqinxi Qigong.
Within-group comparisons of clinical outcomes.
| Outcomes | Variables | WQ Group | Stretching Group | Time * Group | ||||
|---|---|---|---|---|---|---|---|---|
| Pre | Post12wk | Pre vs. Post12wk | Pre | Post12wk | Pre vs. Post12wk |
| ||
|
| ||||||||
| Single-task | Gait speed (cm/s) | 91.03 ± 9.34 | 97.42 ± 10.85 | 0.000 * | 79.85 ± 10.49 | 80.63 ± 13.12 | 0.650 | 0.964 |
| Stride length (cm) | 101.92 ± 11.57 | 107.78 ± 10.57 | 0.001 * | 95.58 ± 11.45 | 95.92 ± 11.59 | 0.118 | 0.001 * | |
| Double support% | 28.83 ± 5.66 | 28.63 ± 5.87 | 0.548 | 33.27 ± 7.79 | 31.36 ± 8.19 | 0.045 * | 0.031 * | |
| Obstacle crossing | Gait speed (cm/s) | 89.29 ± 13.78 | 89.37 ± 17.67 | 0.978 | 74.14 ± 24.52 | 78.53 ± 23.96 | 0.212 | 0.330 |
| Stride length (cm) | 98.21 ± 13.26 | 102.32 ± 12.29 | 0.145 | 92.83 ± 28.56 | 90.05 ± 27.79 | 0.317 | 0.080 | |
| Double support% | 26.19 ± 4.59 | 24.15 ± 3.60 | 0.004 * | 29.45 ± 9.79 | 30.79 ± 10.19 | 0.259 | 0.012 * | |
| Backward digit span | Gait speed (cm/s) | 77.35 ± 20.95 | 75.23 ± 15.41 | 0.524 | 59.86 ± 23.95 | 60.55 ± 26.59 | 0.783 | 0.500 |
| Stride length (cm) | 85.73 ± 15.36 | 85.55 ± 12.17 | 0.951 | 74.97 ± 26.99 | 73.61 ± 27.47 | 0.608 | 0.754 | |
| Double support% | 32.11 ± 5.60 | 31.49 ± 5.22 | 0.596 | 37.49 ± 11.45 | 38.64 ± 10.93 | 0.251 | 0.250 | |
| Serial-3 subtraction | Gait speed (cm/s) | 64.99 ± 18.12 | 66.52 ± 13.84 | 0.544 | 56.19 ± 21.61 | 59.64 ± 24.29 | 0.291 | 0.633 |
| Stride length (cm) | 77.69 ± 13.03 | 82.73 ± 10.39 | 0.021 * | 71.47 ± 25.30 | 73.09 ± 26.11 | 0.587 | 0.336 | |
| Double support% | 34.27 ± 7.33 | 32.13 ± 5.71 | 0.171 | 39.23 ± 11.78 | 38.49 ± 10.75 | 0.593 | 0.494 | |
|
| ||||||||
| MDS-UPDRSIII | 21.63 ± 18.36 | 12.95 ± 9.00 | 0.021 * | 24.15 ± 15.89 | 21.55 ± 16.50 | 0.051 | 0.098 | |
| MDS-UPDRS | 43.78 ± 29.95 | 25.33 ± 16.38 | 0.004 * | 46.55 ± 28.77 | 38.95 ± 32.17 | 0.020 * | 0.084 | |
| TUGT (s) | 11.43 ± 3.48 | 10.05 ± 2.01 | 0.005 * | 11.24 ± 3.90 | 13.19 ± 4.48 | 0.029 | 0.001 * | |
| MiniBESTest | 20.05 ± 7.18 | 24.52 ± 4.20 | 0.023 * | 22.15 ± 5.88 | 22.35 ± 5.61 | 0.779 | 0.038 * | |
| PDQ-39 | 30.00 ± 17.24 | 22.37 ± 15.88 | 0.043 * | 26.79 ± 20.29 | 22.42 ± 18.87 | 0.166 | 0.486 | |
Note. MDS-UPDRS, Movement Disorder Society-the Unified Parkinson’s Disease Rating Scale; MiniBESTest, Mini-Balance Evaluation Systems Test; PDQ-39, 39-item Parkinson’s Disease Questionnaire; TUG, timed-up-and-go test; WQ, Wuqinxi Qigong; * p < 0.05.
Between-group comparisons of changes from baseline for clinical outcomes.
| Outcomes | Variables | Pre vs. Post12wk | |||
|---|---|---|---|---|---|
| WQ Group | Stretching Group |
| Effect Size | ||
|
| |||||
| Single-task | Gait speed (cm/s) | −6.39 ± 5.98 | −0.79 ± 7.43 | 0.045 * | 0.105 |
| Stride length (cm) | −5.85 ± 6.49 | −0.34 ± 0.90 | 0.014 * | 0.152 | |
| Double support% | 0.20 ± 1.49 | 1.53 ± 3.12 | 0.135 | 0.059 | |
| Obstacle crossing | Gait speed (cm/s) | −0.08 ± 12.42 | −4.39 ± 14.76 | 0.041 * | 0.108 |
| Stride length (cm) | −4.11 ± 12.09 | 2.78 ± 11.78 | 0.195 | 0.045 | |
| Double support% | 2.05 ± 2.78 | −1.34 ± 5.02 | 0.041 * | 0.108 | |
| Backward digit span | Gait speed (cm/s) | 2.12 ± 14.62 | −0.70 ± 10.89 | 0.862 | 0.001 |
| Stride length (cm) | 0.17 ± 12.17 | 1.36 ± 11.37 | 0.094 | 0.074 | |
| Double support% | 0.62 ± 5.15 | −1.15 ± 4.22 | 0.025 * | 0.128 | |
| Serial-3 subtraction | Gait speed (cm/s) | −1.52 ± 11.01 | −3.44 ± 13.81 | 0.200 | 0.044 |
| Stride length (cm) | −5.04 ± 8.98 | −1.62 ± 12.76 | 0.201 | 0.044 | |
| Double support% | 2.14 ± 6.74 | 0.74 ± 5.91 | 0.047 * | 0.103 | |
|
| |||||
| MDS-UPDRSIII | 8.68 ± 14.96 | 2.60 ± 5.58 | 0.165 | 0.053 | |
| MDS-UPDRS | 18.44 ± 23.34 | 7.60 ± 13.43 | 0.339 | 0.025 | |
| TUGT (s) | 1.38 ± 1.98 | −1.95 ± 3.71 | 0.155 | 0.051 | |
| MiniBESTest | −4.48 ± 8.33 | −0.20 ± 3.14 | 0.981 | 0.000 | |
| PDQ-39 | 7.63 ± 15.30 | 4.37 ± 13.16 | 0.774 | 0.002 | |
Note. MDS-UPDRS, Movement Disorder Society-the Unified Parkinson’s Disease Rating Scale; MiniBESTest, Mini-Balance Evaluation Systems Test; PDQ-39, 39-item Parkinson’s Disease Questionnaire; TUG, timed-up-and-go test; WQ, Wuqinxi Qigong; * p < 0.05.